Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases

Cites (263)

Items 201–261 of 261

1. Nonalcoholic fatty liver disease is associated with excessive calorie intake rather than a distinctive dietary pattern
   Malte H. Wehmeyer, Birgit‐Christiane Zyriax, Bettina Jagemann, Ewgenia Roth, Eberhard E. T. Windler, Julian Schulze zur Wiesch, Ansgar Wilhelm Lohse, Johannes Kluwe · 2016 · Medicine
2. Monomeric GLP-1/GIP/Glucagon Triagonism Corrects Obesity, Hepatosteatosis, and Dyslipidemia in Female Mice
   Jall, Sigrid, Sachs, Stephan, Clemmensen, Christoffer, Finan, Brian, Neff, Frauke, DiMarchi, Richard D., Tschöp, Matthias H., Müller, Timo D., Hofmann, Susanna M. · 2017 · Molecular Metabolism
3. Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery
   Jonathan Mark Brown, Lawrence L. Rudel · 2010 · Current Opinion in Lipidology
4. Mesenteric Fat Lipolysis Mediates Obesity-Associated Hepatic Steatosis and Insulin Resistance
   Stephan Wueest, Flurin Item, Fabrizio C. Lucchini, Tenagne D. Challa, Werner Müller, Matthias Blüher, Daniel Konrad · 2015 · Diabetes
5. Nocturnal and Postprandial Free Fatty Acid Kinetics in Normal and Type 2 Diabetic Subjects
   John M. Miles, David Wooldridge, Wayne J. Grellner, Sheryl L. Windsor, William L. Isley, Samuel Klein, William Stephen Harris · 2003 · Diabetes
6. New concepts in extracellular signaling for insulin action: the single gateway hypothesis.
   Richard N. Bergman · 1997 · PubMed
7. A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice
   Valdecantos, M. Pilar, Pardo, Virginia, Ruiz, Laura, Castro‐Sánchez, Luis, Lanzón, Borja, Fernández‐Millán, Elisa, García‐Monzón, Carmelo, Arroba, Ana I., González‐Rodríguez, Águeda, Escrivá, Fernando et al. · 2017 · Hepatology
8. Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice
   José M. Irimia, Catalina M. Meyer, Dyann M. Segvich, Sneha Surendran, Anna A DePaoli-Roach, Núria Morral, Peter J. Roach · 2017 · Journal of Biological Chemistry
9. Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver
   Angela M. Hall, Kou Kou, Zhouji Chen, Terri Pietka, Mrudula Kumar, Kevin Korenblat, Kyuha Lee, Kay Ahn, Elisa Fabbrini, Samuel Klein et al. · 2012 · Journal of Lipid Research
10. Increased Whole‐Body Adiposity Without a Concomitant Increase in Liver Fat is Not Associated With Augmented Metabolic Dysfunction
    Faidon Magkos, Elisa Fabbrini, B. Selma Mohammed, Bruce W. Patterson, Samuel Klein · 2010 · Obesity
11. Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases
    Evan Raff, Donny Kakati, Joseph R. Bloomer, Mohamed Shoreibah, Khalid Rasheed, Ashwani Kumar Singal · 2015 · Journal of Clinical and Translational Hepatology
12. Hepatic Transmembrane 6 Superfamily Member 2 Regulates Cholesterol Metabolism in Mice
    Yanbo Fan, Haocheng Lu, Yanhong Guo, Tianqing Zhu, Minerva T. Garcia-Barrio, Zhisheng Jiang, Cristen J. Willer, Jifeng Zhang, Yujie Chen · 2016 · Gastroenterology
13. Mediterranean diet and non-alcoholic fatty liver disease: New therapeutic option around the corner?
    Francesco Sofi · 2014 · World Journal of Gastroenterology
14. Direct and Indirect Effects of Insulin to Inhibit Hepatic Glucose Output in Obese Subjects
    Rudolf Prager, Penny Wallace, Jerrold M. Olefsky · 1987 · Diabetes
15. Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats
    Naoki Kumashiro, Toru Yoshimura, Jennifer L. Cantley, Sachin K. Majumdar, Fitsum Guebre‐Egziabher, Romy Kursawe, Daniel F. Vatner, Ioana Fat, Mario Kahn, Derek M. Erion et al. · 2012 · Hepatology
16. Peroxisome proliferator-activated receptor δ
    Lazar A. Bojic, Murray W. Huff · 2013 · Current Opinion in Lipidology
17. Discovery and Optimization of Imidazopyridine-Based Inhibitors of Diacylglycerol Acyltransferase 2 (DGAT2)
    Futatsugi, Kentaro, Kung, Daniel W., Orr, Suvi T. M., Cabral, Shawn, Hepworth, David, Aspnes, Gary, Bader, Scott, Bian, Jianwei, Boehm, Markus, Carpino, Philip A. et al. · 2015 · Journal of Medicinal Chemistry
18. Hepatic functions of GLP-1 and its based drugs: current disputes and perspectives
    Tianru Jin, Jianping Weng · 2016 · American Journal of Physiology-Endocrinology and Metabolism
19. The Role of the Carbohydrate Response Element-Binding Protein in Male Fructose-Fed Rats
    Derek M. Erion, Violetta Popov, Jennifer J. Hsiao, Daniel F. Vatner, Kisha Anne Mitchell, Shin Yonemitsu, Yoshio Nagai, Mario Kahn, Matthew Paul Gillum, Jianying Dong et al. · 2012 · Endocrinology
20. Acetyl-CoA Carboxylase 2−/− Mutant Mice are Protected against Fatty Liver under High-fat, High-carbohydrate Dietary and de Novo Lipogenic Conditions
    Lutfi A. Abu-Elheiga, Hongmei Wu, Ziwei Gu, RUBIN C. BRESSLER, Salih J. Wakil · 2012 · Journal of Biological Chemistry
21. Application of mitochondrial pyruvate carrier blocker UK5099 creates metabolic reprogram and greater stem-like properties in LnCap prostate cancer cells in vitro
    Yali Zhong, Xiaoran Li, Dandan Yu, Xiaoli Li, Yaqing Li, Yuan Long, Yuan Yuan, Zhenyu Ji, Mingzhi Zhang, Jianguo Wen et al. · 2015 · Oncotarget
22. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study
    Dvir Froylich, Ricard Corcelles, Christopher Ryan Daigle, Mena Boules, Stacy A. Brethauer, Philip R. Schauer · 2015 · Surgery for Obesity and Related Diseases
23. A Noncanonical, GSK3-Independent Pathway Controls Postprandial Hepatic Glycogen Deposition
    Min Wan, Karla F. Leavens, Roger W. Hunter, Shlomit Koren, Alexander von Wilamowitz-Moellendorff, Mingjian Lu, Santhosh Satapati, Qingwei Chu, Kei Sakamoto, Shawn C. Burgess et al. · 2013 · Cell Metabolism
24. Novel Small Molecule Agonist of TGR5 Possesses Anti-Diabetic Effects but Causes Gallbladder Filling in Mice
    Daniel A. Briere, Xiaoping Ruan, Christine Cheng, Angela M. Siesky, Thomas E. Fitch, Carmen Dominguez, Sonia Gutiérrez Sanfeliciano, Carlos Montero, Chen S. Suen, Yanping Xu et al. · 2015 · PLoS ONE
25. Salsalate (Salicylate) Uncouples Mitochondria, Improves Glucose Homeostasis, and Reduces Liver Lipids Independent of AMPK-β1
    Smith, Brennan K., Ford, Rebecca J., Desjardins, Eric M., Green, Alex E., Hughes, Meghan C., Houde, Vanessa P., Day, Emily A., Marcinko, Katarina, Crane, Justin D., Mottillo, Emilio P. et al. · 2016 · Diabetes
26. Paradoxical Dissociation Between Hepatic Fat Content and De Novo Lipogenesis Due to PNPLA3 Sequence Variant
    Rosellina Margherita Mancina, Niina Matikainen, Cristina Maglio, Sanni Söderlund, Nina M I Lundbom, Antti Hakkarainen, Raffaela Rametta, Enrico Mozzi, Silvia Rossana Fargion, Luca V. C. Valenti et al. · 2015 · The Journal of Clinical Endocrinology & Metabolism
27. Genome-wide association studies in East Asians identify new loci for waist-hip ratio and waist circumference
    Wanqing Wen, Norihiro Kato, Joo‐Yeon Hwang, Xingyi Guo, Yasuharu Tabara, Huaixing Li, Rajkumar Dorajoo, Xiaobo Yang, Fuu‐Jen Tsai, Shengxu Li et al. · 2016 · Scientific Reports
28. Combined Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Sleeve Gastrectomy or Gastric Bypass?—a Controlled Matched Pair Study of 34 Patients
    Adrian Theophil Billeter, Jonas D. Senft, Daniel Nils Gotthardt, Philipp Knefeli, Felix Nickel, Thilo Schulte, Lars Fischer, Peter P. Nawroth, Markus Wolfgang Büchler, Beat Peter Müller-Stich · 2015 · Obesity Surgery
29. CREBH-FGF21 axis improves hepatic steatosis by suppressing adipose tissue lipolysis
    Jong‐Gil Park, Xu Xu, Sungyun Cho, Kyu Yeon Hur, Myung‐Shik Lee, Sander Kersten, Ann–Hwee Lee · 2016 · Scientific Reports
30. The Relation of Insulin to Liver Metabolism
    Rachmiel Levine, Irving B. Fritz · 1956 · Diabetes
31. Time-dependent effects of Prkce deletion on glucose homeostasis and hepatic lipid metabolism on dietary lipid oversupply in mice
    Katy Raddatz, Nigel A. Turner, Georgia Frangioudakis, B. M. Liao, David J. Pedersen, James Cantley, Donna L. Wilks, Elaine Preston, Bronwyn D. Hegarty, Michael Leitges et al. · 2011 · Diabetologia
32. Liver X receptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity
    Christian Bindesbøll, Qiong Fan, Rikke C. Nørgaard, Laura MacPherson, Hai‐Bin Ruan, Jing Wu, Thomas Åskov Pedersen, Knut Rune Steffensen, Xiaoyong Yang, Jason B. Matthews et al. · 2015 · Journal of Lipid Research
33. Abrogating Monoacylglycerol Acyltransferase Activity in Liver Improves Glucose Tolerance and Hepatic Insulin Signaling in Obese Mice
    Angela M. Hall, Nisreen Soufi, Kari T. Chambers, Zhouji Chen, George G. Schweitzer, Kyle S. McCommis, Derek M. Erion, Mark J. Graham, Xiong Su, Brian N. Finck · 2014 · Diabetes
34. Aerobic exercise training in the treatment of non‐alcoholic fatty liver disease related fibrosis
    Melissa A. Linden, Ryan D. Sheldon, Grace Margaret-Eleanor Meers, Laura Christine Ortinau, E. Matthew Morris, Frank W. Booth, Jill A. Kanaley, Victoria J. Vieira‐Potter, James R. Sowers, Jamal A. Ibdah et al. · 2016 · The Journal of Physiology
35. The dynamic organization of fungal acetyl-CoA carboxylase
    Moritz Hunkeler, Edward Stuttfeld, A. Hagmann, Stefan Imseng, Timm Maier · 2016 · Nature Communications
36. Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial
    Matthew James Armstrong, Darren Barton, Piers Gaunt, Diana Hull, Kathy Guo, Deborah D. Stocken, Stephen C. L. Gough, Jeremy Tomlinson, Rachel Mary Brown, Stefan G. Hübscher et al. · 2013 · BMJ Open
37. A critical evaluation of mass isotopomer distribution analysis of gluconeogenesis in vivo
    Stephen F. Previs, Gary W. Cline, Gerald I. Shulman · 1999 · American Journal of Physiology-Endocrinology and Metabolism
38. Inhibiting Monoacylglycerol Acyltransferase 1 Ameliorates Hepatic Metabolic Abnormalities but Not Inflammation and Injury in Mice
    Nisreen Soufi, Angela M. Hall, Zhouji Chen, Jun Yoshino, Sara L. Collier, James C. Mathews, Elizabeth M. Brunt, Carolyn J. Albert, Mark J. Graham, David A. Ford et al. · 2014 · Journal of Biological Chemistry
39. The Amelioration of Hepatic Steatosis by Thyroid Hormone Receptor Agonists Is Insufficient to Restore Insulin Sensitivity in Ob/Ob Mice
    Alexandro J. Martagón, Jean Z. Lin, Stephanie L. Cimini, Paul Webb, Kevin J. Phillips · 2015 · PLoS ONE
40. Diacylglycerol acyltransferase-1 inhibition enhances intestinal fatty acid oxidation and reduces energy intake in rats
    Gudrun Schober, Myrtha Arnold, Susan Birtles, Linda K. Buckett, Gustavo Pacheco‐López, Andrew V. Turnbull, Wolfgang Langhans, Abdelhak Mansouri · 2013 · Journal of Lipid Research
41. A controlled-release mitochondrial protonophore reverses hypertriglyceridemia, nonalcoholic steatohepatitis, and diabetes in lipodystrophic mice
    Abulizi, Abudukadier, Perry, Rachel J., Camporez, João Paulo G., Jurczak, Michael J., Petersen, Kitt Falk, Aspichueta, Patricia, Shulman, Gerald I. · 2017 · The FASEB Journal
42. Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humans
    Benjamin S. Maciejewski, Jennifer L. LaPerle, Danny Chen, Avijit Ghosh, William J. Zavadoski, Thomas S. McDonald, Tara B. Manion, Dawn Mather, Terrell Ann Patterson, Maya Hanna et al. · 2013 · American Journal of Physiology-Gastrointestinal and Liver Physiology
43. Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content
    Andreas Peter, Kοnstantinos Kantartzis, Fausto E Machicao, Jürgen Machann, Silvia Wagner, Silke Templin, Ingmar Königsrainer, Alfred Königsrainer, Fritz Schick, Andreas Fritsche et al. · 2011 · International Journal of Obesity
44. Discovery of a Potent and Orally Efficacious TGR5 Receptor Agonist
    Sameer Agarwal, Amit Patil, Umesh Aware, Prashant H. Deshmukh, Brijesh Darji, Santosh Sasane, Kalapatapu V. V. M. Sairam, Priyanka Priyadarsiny, Poonam Giri, Harilal Patel et al. · 2015 · ACS Medicinal Chemistry Letters
45. BMS-986036 (pegylated FGF21) in patients with non-alcoholic steatohepatitis: a phase 2 study
    Arun Jayant Sanyal, Edgar D. Charles, Brent A. Neuschwander‐Tetri, Rohit Seth Loomba, Stephen A. Harrison, Manal F. Abdelmalek, Eric Lawitz, Dina L. Halegoua-DeMarzio, Yan Dong, Stephanie Noviello et al. · 2017 · Journal of Hepatology
46. JTP-103237, a novel monoacylglycerol acyltransferase inhibitor, modulates fat absorption and prevents diet-induced obesity
    Chihiro Okuma, Takeshi Ohta, Hironobu Tadaki, Hiromi Hamada, Tomohiro Oda, Hideyuki Taniuchi, Kenji Yamanaka, Yukihito Ishii, Yasuhiro Ohe, Shinji Yata et al. · 2015 · European Journal of Pharmacology
47. TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
    Shitalkumar P. Zambad, Davinder Tuli, A Matur, Sameer Ghalsasi, Anita Chaudhary, Shailesh Deshpande, Ramesh Gupta, Vijay M. Chauthaiwale, Chaitanya Dutt · 2013 · Diabetes Metabolic Syndrome and Obesity
48. Effects of short‐term energy restriction on liver lipid content and inflammatory status in severely obese adults: R esults of a randomized controlled trial using 2 dietary approaches
    Emma L. Baldry, Guruprasad Padur Aithal, Philip Kaye, ISKANDAR RAUF IDRIS, Andrew J. Bennett, Paul Constantine Leeder, Ian Andrew Macdonald · 2017 · Diabetes Obesity and Metabolism
49. Omentectomy in Addition to Bariatric Surgery—a 5-Year Follow-up
    Daniel Peter Andersson, Daniel Eriksson Hogling, Jesper Bäckdahl, Anders Thorell, Patrik Löfgren, Mikael Rydén, Peter Arner, Johan Hoffstedt · 2017 · Obesity Surgery
50. Diacylglycerol kinase θ couples farnesoid X receptor-dependent bile acid signalling to Akt activation and glucose homoeostasis in hepatocytes
    Kai Cai, Marion B. Sewer · 2013 · Biochemical Journal
51. APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases
    Rui-Nan Zhang, Rui-dan Zheng, Yuqiang Mi, Da Zhou, Feng Shen, Guangyu Chen, Chanyan Zhu, Qin Pan, Jian‐Gao Fan · 2016 · Digestive Diseases and Sciences
52. Increased hepatic mitochondrial FA oxidation reduces plasma and liver TG levels and is associated with regulation of UCPs and APOC-III in rats
    Carine Lindquist, Bodil Bjørndal, Christine Renate Rossmann, Deusdedit Tusubira, Asbjørn M. Svardal, Gro Vatne Røsland, Karl Johan Tronstad, Seth Hallström, Rolf Kristian Berge · 2017 · Journal of Lipid Research
53. Discovery and Pharmacology of a Novel Class of Diacylglycerol Acyltransferase 2 Inhibitors
    Jason E. Imbriglio, Dong‐Ming Shen, Rui Liang, Ken Marby, Ming You, Hye Won Youm, Zhe Feng, Clare London, Yusheng Xiong, Jim Tata et al. · 2015 · Journal of Medicinal Chemistry
54. JTT-553, a novel Acyl CoA:diacylglycerol acyltransferase (DGAT) 1 inhibitor, improves glucose metabolism in diet-induced obesity and genetic T2DM mice
    Daisuke Tomimoto, Chihiro Okuma, Yukihito Ishii, Akio Kobayashi, Takeshi Ohta, Makoto Kakutani, Tsuneo Imanaka, Nobuya Ogawa · 2015 · Journal of Pharmacological Sciences
55. Discovery of Selective Small Molecule Inhibitors of Monoacylglycerol Acyltransferase 3
    Kim Huard, Allyn T. Londregan, Gregory J. Tesz, Kevin B. Bahnck, Thomas V. Magee, David Hepworth, Jana Polívková, Steven B. Coffey, Brandon A. Pabst, James R. Gosset et al. · 2015 · Journal of Medicinal Chemistry
56. Piperazine Oxadiazole Inhibitors of Acetyl-CoA Carboxylase
    Matthew P. Bourbeau, Aaron Siegmund, John G. Allen, Hong Shu, Christopher H. Fotsch, Michael D. Bartberger, Kiwon Kim, Renée Komorowski, Melissa Graham, James Busby et al. · 2013 · Journal of Medicinal Chemistry
57. NGM282, a novel variant of FGF19, significantly reduces hepatic steatosis and key biomarkers of NASH: results of a Phase 2, multicenter, randomized, double-blinded, placebo controlled trial in biopsy-confirmed NASH patients
    Stephen A. Harrison, Manal F. Abdelmalek, J.F. Trotter, Angelo H. Paredes, Hays L. Arnold, Marcelo Kugelmas, M.R. Bashir, L. Ling, S.J. Rossi, Alex M. DePaoli et al. · 2017 · Journal of Hepatology
58. JTP-103237, a monoacylglycerol acyltransferase inhibitor, prevents fatty liver and suppresses both triglyceride synthesis and de novo lipogenesis
    Chihiro Okuma, Takeshi Ohta, Hironobu Tadaki, Tatsuya Ishigure, Shohei Sakata, Hideyuki Taniuchi, Ryuhei Sano, Hiromi Hamada, Shinichi KUME, Jun Nishiu et al. · 2015 · Journal of Pharmacological Sciences
59. Potential mechanism of enhanced postprandial glucagon‐like peptide‐1 release following treatment with a diacylglycerol acyltransferase 1 inhibitor
    Jinqi Liu, David G. McLaren, Dunlu Chen, Yanqing Kan, Steven J. Stout, Xiaolan Shen, Beth Ann Murphy, Gail Forrest, Bindhu V. Karanam, Lisa M. Sonatore et al. · 2015 · Pharmacology Research & Perspectives
60. Phenotypic Discrepancies in Acetyl-CoA Carboxylase 2-deficient Mice
    Kyle L. Hoehn, Nigel A. Turner, George J. Cooney, David Ernest James · 2012 · Journal of Biological Chemistry
61. Editors’ Introduction to the NAFLD and NASH Special Issue
    Michael A. Fuchs, Bernd Schnabl · 2016 · Digestive Diseases and Sciences